Alcohol and Drug Abuse

Transparency in scientific review and recommendations for the 2025 Dietary Guidelines for Americans

US Dietary Guidelines

Explore grant opportunities and educate on the work of Chestnut Health Systems.

diversion funding

Drug and alcohol prevention programs: in support of robust funding for substance abuse prevention programs, including in out-of-school time settings.

Opioids, pain management Federal funding for substance use disorder treatments H.R.2004-Tylers Law, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose H.R. 2483-Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder S.921-Tylers Law, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose S. 2121-Support for Patients and Communities Reauthorization Act, to reauthorize grants and programs to address opioid and substance use disorder S. 3522-No Red Tape for Addiction Treatment Act, to require that State Medicaid programs provide at least one formulation of each type of medication for the treatment of opioid use disorder without prior authorization or limitations on dosage

H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery (SPEED) Act H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025

Responsible drinking initiatives. Issues related to sale of distilled spirits.

Issues related to federal prisons, medically assisted treatment, opioid and substance use disorder, healthcare, telehealth, criminal justice, Medicaid and Medicare

Health care policy issues related to substance use disorder treatment, including federal programs, reimbursement, and access to care.

Anti-Doping efforts.

Controlled Substances Prescribing & Dispensing; Comments to DOJ & DEA on "Ensuring Lawful Governance and Implementing the Presidents 'Department of Government Efficiency' Deregulatory Initiative"; Comments to DEA on "Special Registrations for Telemedicine and Limited State Telemedicine Registrations [Docket No. DEA-407]" Comments to DEA on "Update to DEA Registration Process for Pharmacists to Reflect State Law Changes"

Horseracing Integrity & Safety Act. OBBBA.

Legislative proposals to close the "hemp loophole" in the Farm Bill of 2018. Proposals to cap THC potency, reform marketing and packaging of products containing THC, enhance data collection and education activities.

Monitoring issues related to the insurance industry.

neonatal abstinence syndrome research, contingency management

Food and beverage policy issues, including 2025-2030 Dietary Guidelines for America. H.R. 5371, Continuing Appropriations including Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2026, provisions related to food and beverage policies.

Labeling and Permitting Marketing and Advertising Trade Practices Competition in the Marketplace Dietary Guidelines

Issues related to state-based regulation of alcohol. Issues related to funding and oversight of the Alcohol and Tobacco Tax and Trade Bureau (TTB). Issues related to regulation and enforcement of alcohol. Issues related to President Biden's Executive Order on Promoting Competition in the American Economy. Issues related to the differentiation between beer, wine and liquor. Issues related to the 2025-2030 Dietary Guidelines for Americans. Issues related to the ability of TTB to operate as a separate Bureau under the jurisdiction of the Department of the Treasury. Issues related to alcohol diversion.

**Issues lobbied without specific bill number: Marijuana Research

**Issues lobbied without specific bill number: Marijuana Research

Opioids/ Substance Use Disorder MATE ACT Adds New Education Mandate for 8 Hours of Continuing Education on Opioid Treatment H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act Issues related to opioids and substance use disorder - no specific bill

Issues relating to Kratom products and regulations.

Underage drinking prevention generally. Drunk driving prevention generally.

General education to advance federal funding and policies to support continued alcohol research and strategies to address alcohol related disorders.

Legislative monitoring and outreach regarding consumer protections on Kratom products. Draft, Kratom Consumer Protection Act.

Advocate for expanded behavioral health and addiction recovery services.

Discussed various community responses to addiction issues, and pushed to maintain Comprehensive Opioid, Stimulant, and Substance Use Program grants.

Expand funding and flexibility to address all substance use disorders: H.R. 4030 - Treatment Continuity Act of 2025

-Expand access to medication-assisted treatment -Drug Enforcement Agency (DEA) - rules for prescribing controlled medications via telemedicine